Fortress Biotech
(NASDAQ) FBIOP
Fortress Biotech Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$63.25M
Net Income (TTM)
$6.82M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$13.51
Volume
100
Open
$13.51
Price
$13.51
Volume
100
Open
$13.51
Previous Close
$13.51
Daily Range
$13.51 - $13.51
52-Week Range
$4.72 - $14.64
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$13.51
Volume
100
Open
$13.51
Previous Close
$13.51
Daily Range
$13.51 - $13.51
52-Week Range
$4.72 - $14.64
FBIOP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fortress Biotech
FBIOP Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-1%
Net Income Margin
11%
Return on Equity
0%
Return on Capital
-52%
Return on Assets
4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
9.74%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
100
Short Interest
0.00%
Avg. Volume
23.27K
Financials (TTM)
Gross Profit
$42.34M
Operating Income
$70.22M
EBITDA
$20.16M
Operating Cash Flow
$65.78M
Capital Expenditure
$0.00
Free Cash Flow
$65.78M
Cash & ST Invst.
$79.38M
Total Debt
$74.30M
Fortress Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$16.07M
+6.3%
Gross Profit
$10.64M
+14.2%
Gross Margin
66.22%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
101
N/A
Net Income
$3.94M
+41.8%
EBITDA
$3.18M
+85.4%
Quarterly Fundamentals
Net Cash
$5.08M
+127.2%
Accounts Receivable
$29.94M
+187.8%
Inventory
$9.62M
-33.3%
Long Term Debt
$72.17M
-0.7%
Short Term Debt
$2.13M
-34.5%
Return on Assets
3.67%
N/A
Return on Invested Capital
-51.71%
N/A
Free Cash Flow
$12.54M
+2.8%
Operating Cash Flow
$12.54M
+2.8%